Skip to main content

#156420

Anti-Pfalciparum Histidine Rich Protein 2 [299-2H 4A5 ]

Cat. #156420

Anti-Pfalciparum Histidine Rich Protein 2 [299-2H 4A5 ]

Cat. #: 156420

Unit size: 100 ug

Availability: 10-12 weeks

Target: aldolase

Class: Monoclonal

Application: IHC

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Johns Hopkins University

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Pfalciparum Histidine Rich Protein 2 [299-2H 4A5 ]
  • Research fields: Immunology;Microbiology
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Application: IHC
  • Description: Hybridoma clone 299-2 HRPII 4A5 producing the monoclonal antibodies that are specific to an abundant malaria protein called histidine rich protein 2 specific to Plasmodium falciparum. The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite.

Target Details

  • Target: aldolase
  • Target background: Hybridoma clone 299-2 HRPII 4A5 producing the monoclonal antibodies that are specific to an abundant malaria protein called histidine rich protein 2 specific to Plasmodium falciparum. The antibody can be used for diagnostic testing or immunohistochemical detection of the malaria parasite.

Applications

  • Application: IHC

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Lee et al. 2006. J Clin Microbiol. 44(8):2773-8. PMID: 16891491.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.